April 24, 2026
According to Payal Rabde, who specializes in oncology biosimilars, inflammatory disease management, targeted biologic therapies, and biosimilar versions of monoclonal antibody therapies, with 4+ years of experience in market research and industry ana...
April 17, 2026
Biosimilar Contract Manufacturing Market (By Source: Mammalian, Non-mammalian; By Services: Recombinant Non-glycosylated Proteins, Recombinant Glycosylated Proteins; By Therapeutic Area: Oncology, Blood Disorders, Growth Hormonal Deficiency, Chronic ...
April 30, 2026
Biosimilar Antibodies Market (By Molecular Type: Monoclonal Antibodies (mAbs), Fusion Proteins; By Application: Oncology, Autoimmune Diseases, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; By Region: Nort...
July 06, 2026
According to Rohan Patil, who specializes in biopharmaceuticals, biosimilars, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, the biosimilars market is set for strong long-term expansion, grow...
April 21, 2026
Projections indicate that, the global aflibercept biosimilars market will increase from USD 1.54 billion in 2024 to USD 3.7 billion by 2034, experiencing a CAGR of 9.14% over the next 10 years. The maturing ophthalmic biosimilar ecosystem is estimate...
April 21, 2026
According to market estimations the global generic sterile injectable market was estimated at US$ 51.23 billion in 2025 and is projected to grow to US$ 82.14 billion by 2030. In 2023, North America led the market with a 40% share. Monoclonal antibodi...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
+1 9197 992 333
+91 93077 85324
